Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies
Authors
Keywords
-
Journal
CANCER GENE THERAPY
Volume 18, Issue 1, Pages 2-11
Publisher
Springer Nature
Online
2010-10-22
DOI
10.1038/cgt.2010.63
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MdmX regulates transformation and chromosomal stability in p53-deficient cells
- (2011) Zdenka Matijasevic et al. CELL CYCLE
- p53 Regulates the Ras Circuit to Inhibit the Expression of a Cancer-Related Gene Signature by Various Molecular Pathways
- (2010) Y. Buganim et al. CANCER RESEARCH
- Mutations in the tetramerization domain of p53: More than just keeping monomers apart
- (2010) Ido Goldstein et al. CELL CYCLE
- Characterization of a new cancer-associated mutant of p53 with a missense mutation (K351N) in the tetramerization domain
- (2010) Michela Muscolini et al. CELL CYCLE
- Mutant p53-induced Up-regulation of Mitogen-activated Protein Kinase Kinase 3 Contributes to Gain of Function
- (2010) Aymone Gurtner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ablation of Key Oncogenic Pathways by RITA-Reactivated p53 Is Required for Efficient Apoptosis
- (2009) Vera V. Grinkevich et al. CANCER CELL
- PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
- (2009) Jeremy M.R. Lambert et al. CANCER CELL
- HIPK2 Regulation by MDM2 Determines Tumor Cell Response to the p53-Reactivating Drugs Nutlin-3 and RITA
- (2009) C. Rinaldo et al. CANCER RESEARCH
- Promyelocytic Leukemia Protein is Required for Gain of Function by Mutant p53
- (2009) S. Haupt et al. CANCER RESEARCH
- Modes of p53 Regulation
- (2009) Jan-Philipp Kruse et al. CELL
- A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
- (2009) Maddalena Adorno et al. CELL
- A Regulatory Loop Composed of RAP80-HDM2-p53 Provides RAP80-enhanced p53 Degradation by HDM2 in Response to DNA Damage
- (2009) Jun Yan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosis
- (2009) V Marcel et al. JOURNAL OF MEDICAL GENETICS
- Identification of New p53 Acetylation Sites in COS-1 Cells
- (2009) Anita Joubel et al. MOLECULAR & CELLULAR PROTEOMICS
- Wrap53, a Natural p53 Antisense Transcript Required for p53 Induction upon DNA Damage
- (2009) Salah Mahmoudi et al. MOLECULAR CELL
- p53 mutations as fingerprints for aristolochic acid – an environmental carcinogen in endemic (Balkan) nephropathy
- (2009) Neda Slade et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- p53 isoforms Δ133p53 and p53β are endogenous regulators of replicative cellular senescence
- (2009) Kaori Fujita et al. NATURE CELL BIOLOGY
- The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis
- (2009) Giulia Fontemaggi et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Recent advances in p53 research: an interdisciplinary perspective
- (2008) M Olivier et al. CANCER GENE THERAPY
- Nutlin-3a Activates p53 to Both Down-regulate Inhibitor of Growth 2 and Up-regulate mir-34a, mir-34b, and mir-34c Expression, and Induce Senescence
- (2008) K. Kumamoto et al. CANCER RESEARCH
- Peptide Aptamers Targeting Mutant p53 Induce Apoptosis in Tumor Cells
- (2008) E. Guida et al. CANCER RESEARCH
- SIRT1 Regulates Apoptosis and Nanog Expression in Mouse Embryonic Stem Cells by Controlling p53 Subcellular Localization
- (2008) Myung-Kwan Han et al. Cell Stem Cell
- The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss
- (2008) T. Terzian et al. GENES & DEVELOPMENT
- TP53mutation signature supports involvement of aristolochic acid in the aetiology of endemic nephropathy-associated tumours
- (2008) Tatiana Nedelko et al. INTERNATIONAL JOURNAL OF CANCER
- Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype
- (2008) Helene R. McMurray et al. NATURE
- Activation of p53 by nutlin leads to rapid differentiation of human embryonic stem cells
- (2008) T Maimets et al. ONCOGENE
- Cancer cells suppress p53 in adjacent fibroblasts
- (2008) J Bar et al. ONCOGENE
- Targeted rescue of a destabilized mutant of p53 by an in silico screened drug
- (2008) F. M. Boeckler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Oncogene-Induced DNA Damage Model for Cancer Development
- (2008) T. D. Halazonetis et al. SCIENCE
- Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
- (2008) Jean-Philippe Coppé et al. PLOS BIOLOGY
- Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53
- (2008) Jennifer J. Jordan et al. PLoS Genetics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation